Ang-(1-7) might prevent the development of monocrotaline induced pulmonary arterial hypertension in rats

European Review for Medical and Pharmacological Sciences

Volumn 15, Issue 1, 2011, Pages 1-7

  Chen, L ^a   Xiao, J ^a   Li, Y ^b   Ma, Hong ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); Endothelial nitric oxide synthase; Monocrotaline; Pulmonary arterial hypertension

Indexed keywords

ANGIOTENSIN[1-7]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MONOCROTALINE; PROTEIN KINASE B; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; INTERMETHOD COMPARISON; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RAT; RIGHT VENTRICULAR SYSTOLIC PRESSURE; SYSTOLIC BLOOD PRESSURE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HEMODYNAMICS; IDIOPATHIC PULMONARY HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANGIOTENSIN I; ANIMALS; HEMODYNAMICS; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79953135292     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BROSNIHAN KB, LI P, FERRARIO CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27(Part 2): 523-528.
2. CHAPPELL MC, PIRRO NT, SYKES A, FERARIO C. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 1998; 31 (Part 2): 362-367.
3. DIMMELER S, DERNBACH E, ZEIHER AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 2000; 477: 258-262.
4. DONOGHUE M, HSIEH F, BARONAS E, GODBOUT K, GOSSELIN M, STAGLIANO N, DONOVAN M, WOOLF B, ROBISON K, JEYASEELAN R, BREITBART RE, ACTON S. A novel angiotensin converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Res 2000; 87: E1-E9.
5. FERNANDES L, FORTES ZB, NIGRO D, TOSTES RC, SANTOS RA, CATELLI DE CARVALHO MH. Potentiation of bradykinin by angiotensin (1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension 2001; 37: 703-709.
6. FISSLTHALER B, DIMMELER S, HERMANN C, BUSSE R, FLEMING I. Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand 2000; 168: 81-88.
7. FREEMAN EJ, CHISOLM GM, FERRARIO CM, TALLANT EA. Angiotensin (1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28: 104-108.
8. HEITSCH H, BROVKOVYCH S, MALINSKI T, WIEMER G. Angiotensin-(1-7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001; 37: 72-76.
9. IYER SN, CHAPPELL MC, AVERILL DB, DIZ DI, FERRARIO CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998; 31: 699-705.
10. MONCADA S, HIGGS EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006; 147: S193-S201.
11. MUTHALIF MM, BENTER IF, UDDIN MR, HARPER JL, MALIK KU. Signal transduction mechanism involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth cells. J Pharmacol Exp Ther 1998; 284: 388-398.
12. NAKASHIMA H, SUZUKI H, OHTSU H, CHAO JY, UTSUNOMIYA H, FRANK GD, EGUCHI S. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006; 4: 67-78.
13. REN Y, GARVIN JL, CARRETERO OA. Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles. Hypertension 2002; 39: 799-802.
14. SANTOS RA, FERREIRA AJ, PINHEIRO SV, et al. Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs. Expert Opin Investig Drugs 2005; 14: 1019-1031.
15. SANTOS RA, BROSNIHAN KB, JACOBSEN DW, DICORLETO PE, FERRARIO CM. Production of angiotensin-(1-7) by human vascular endothelium. Hypertension 1992; 19(2Suppl): II56-II61.
16. SANTOS RAS, CAMPAGNOLE-SANTOS MJ, ANDRADE SP. Angiotensin-(1-7): an update. Regulatory Peptides 2000; 91: 45-62.
17. SASAKI S, HIGASHI Y, NAKAGAWA K, MATSUURA H, KAJIYAMA G, OSHIMA T. Effects of angiotensin-(1-7) on forearm circulation in normotensive subjects and patients with essential hypertension. Hypertension 2001; 38: 90-94.
18. SCHMAIER AH. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction. Am J Physiol 2003; 285: R1-R13.
19. KANNO S, WU YJ, LEE PC, BILLIAR TR, HO C. Angiotensin-Converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats. Circulation 2001; 104: 945-950.
20. STRAWN WB, FERRARIO CM, TALLANT EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 1999; 33: 207-211.
21. TAYLOR DW, WILSON DW, LAMÉ MW, DUNSTON SD, JONES AD, SEGALL HJ. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells. Toxicol Appl Pharmacol 1997; 143: 196-204.
22. THOMAS HC, LAMÉ MW, DUNSTON SK, SEGALL HJ, WILSON DW. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells. Toxicol Appl Pharmacol 1998; 151: 236-244.
23. TYLER RC, MURAMATSU M, ABMAN SH, STELZNER TJ, RODMAN DM, BLOCH KD, MCMURTRY IF. Variable expression of endothelial NO synthase in three forms of rat pulmonary hypertension. Am J Physiol 1999; 276: L297-L303.
24. WAGNER JG, PETRY TW, ROTH RA. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium. Am J Physiol 1993; 264(5Pt1): L517-L522.
25. SAMPAIO WO, SOUZA DOS SANTOS RA, FARIA-SILVA R, DA MATA MACHADO LT, SCHIFFRIN EL, TOUYZ RM. Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 2007; 49: 185-192.
26. WANG Y, NAGASE S, KOYAMA A. Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. Nitric Oxide 2004; 10: 25-35.
27. VICKERS C, HALES P, KAUSHIK V, DICK L, GAVIN J, TANG J, GODBOUT K, PARSONS T, BARONAS E, HSIEH F, ACTON S, PATANE M, NICHOLS A, TUMMINO P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 2002; 277: 4838-4843.